PHIA Koninklijke Philips N.V.

Philips extends leadership in virtually helium-free MRI with more than 1,000 systems installed, expanding patient access worldwide

Philips extends leadership in virtually helium-free MRI with more than 1,000 systems installed, expanding patient access worldwide

February 28, 2024

At #ECR2024, company also debuting Europe’s first mobile virtually helium-free MRI system

Amsterdam, the Netherlands and Vienna, Austria – (NYSE: PHG, AEX: PHIA), a global leader in health technology, today announced a significant milestone as it expands access to virtually helium-free [1] MRI to more patients in more places, with more than 1,000 systems now installed worldwide. As healthcare providers strive to deliver high-quality care to patients, at Philips is partnering with its customers to improve productivity and access to more sustainable healthcare.

Philips BlueSeal magnet is the industry's first 1.5T fully sealed magnet and requires only 0.5% of the helium of a conventional Philips MR system. By dramatically easing installation requirements and addressing helium scarcity, the is helping more patients in diverse locations benefit from a technology that plays an essential role in diagnosing many of the world’s most prevalent diseases.

Philips BlueSeal technology is expanding the reach of MRI to places where it was previously too difficult to install and maintain, including remote and isolated locations, and those prone to tropical storms, earthquakes, and other geographical obstacles. With a magnet that’s 900kg lighter than a traditional system [2] and doesn’t require a quench pipe – required for traditional MR systems to safely expel their large volume of helium out of a building quickly in case of an emergency – Philips MR systems equipped with BlueSeal magnets can be installed in places that were previously unthinkable.

“We wanted to set up the MRI in the basement of a building in the middle of the city center to provide better access to care for our patients. Not having a quench pipe to expel helium out of the building in the event of an emergency was very important to us due to the location of the MRI system,” said Hiroyuki SUGAYA, M.D., President, Tokyo Sports & Orthopedic Clinic, Tokyo, Japan. “We also needed an MRI system that would be a good financial investment, significantly reducing construction costs and reducing the need to refill helium.”

First installed in 2018, Philips’ BlueSeal magnet is a proven and reliable technology that is rapidly reshaping patient access to MRI worldwide. Patients on remote island areas in Indonesia and Thailand, as well those in areas at risk of earthquakes and volcanoes in Iceland and Japan, are already benefiting from the technology.

Philips is now bringing its innovation in virtually helium-free MRI to a mobile truck, with the first  [3] developed in Europe for Denmark-based making its debut at #ECR2024. MR systems equipped with Philips’ BlueSeal magnet technology have saved more than 1.9 million liters of helium since 2018 [4].

“The rapid global adoption of our virtually helium-free MR technology is a strong example of how we are improving the lives of patients, expanding access to cutting-edge imaging technology,” said Ruud Zwerink, Business Leader of MR at Philips. “With over 1,000 systems installed globally, our proven technology is bringing MRI closer to patients wherever it’s needed, as well as providing an answer to .”

[1] Systems contain 7 liters of helium, fully sealed, no helium can leave the system.

[2] Compared to Philips earlier (non-BlueSeal) Ingenia 1.5T ZBO magnet.

[3] BlueSeal mobile 1.5T is considered a work in progress and is not CE marked and not available for sale.  

[4] The amount of liquid helium saved is calculated compared to a classic magnet with 1,500 liters of helium.

For further information, please contact:

Kathy O’Reilly

Philips Global External Relations

Tel.:

E-mail:

About Royal Philips

Royal Philips (NYSE: PHG, AEX: PHIA) is a leading health technology company focused on improving people's health and well-being through meaningful innovation. Philips’ patient- and people-centric innovation leverages advanced technology and deep clinical and consumer insights to deliver personal health solutions for consumers and professional health solutions for healthcare providers and their patients in the hospital and the home. Headquartered in the Netherlands, the company is a leader in diagnostic imaging, ultrasound, image-guided therapy, monitoring, and enterprise informatics, as well as in personal health. Philips generated 2023 sales of EUR 18.2 billion and employs approximately 69,700 employees with sales and services in more than 100 countries. News about Philips can be found at .

Attachments



EN
28/02/2024

Underlying

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on Koninklijke Philips N.V.

 PRESS RELEASE

Nicklaus Children’s Health System, Philips to provide innovative patie...

Nicklaus Children’s Health System, Philips to provide innovative patient and staff experience, helping to enhance outcomes for the smallest of patients April 30, 2024 Philips AI-enabled diagnostic and experiential technologies help put patients at ease while empowering staff with faster, high-quality scans and increased diagnostic confidence Amsterdam, the Netherlands, and Miami, US – (NYSE: PHG, AEX: PHIA), a global leader in health technology, and Nicklaus Children’s Health System, a nationally recognized leader in pediatric care, today announced a 10-year long-term strategic collabora...

Marc Hesselink ... (+3)
  • Marc Hesselink
  • CFA
  • Thymen Rundberg

Philips/Very welcome clearing event/HOLD

At its 1Q24 update Philips surprised the market with a personal injury settlement which has been made much sooner than expected and, at €1bn, is a much lower cost than the €3bn we had in our model. We believe this is a major positive for the investment case. We increase our target price from €19 to €25. We stick to our HOLD rating as: (1) current trading conditions are mixed; and (2) valuation is now fair compared to peers.

ING Helpdesk
  • ING Helpdesk

Benelux Morning Notes

Alfen: Production resumed in mid-April, cost hit €5m. Exor: Read-across from Philips personal injury settlement. Philips: 1Q24 results – settlement reached. Recticel: 1Q24 in line with expectations. Sofina: Exit Petit Forestier

ResearchPool Subscriptions

Get the most out of your insights

Get in touch